See what a Commercial Readiness Assessment actually produces

A complete sample report on a fictional company. Tell me who you are and I will send it over.

Most companies in life science tools and diagnostics can tell you what revenue did last quarter. Far fewer can tell you whether the engine that produced it will hold next quarter, and fewer still can tell you where their own leaders disagree about it.

That is what the Commercial Readiness Assessment measures. Five to eight of your leaders each spend 30 to 45 minutes rating 42 statements about how the commercial organization actually runs, across nine areas that go from market strategy through forecast integrity to customer retention. Their answers produce a Commercial Readiness Index score, a clear view of where the leadership team agrees and where it does not, and a ranked list of the gaps costing you the most.

I have sat through a lot of assessments over thirty years in this sector, and most of them end in a report nobody uses. This one produces a number, which means you can run it again in a year and see whether anything actually moved.

Why do it

Most commercial organizations only get a real checkup when something hurts: a missed quarter, a lost renewal, a rep who never ramped. The CRA is a structured look taken while the dashboard still reads green, so small problems get fixed before they turn into forecast misses or board surprises. When most of the revenue is already under contract, that lead time matters more, not less. A weak selling and renewal motion costs nothing for years, and then costs a great deal all at once.

• Independent second set of eyes. An outside, operator grade read on the questions a board or a buyer will ask.
• Validates where to invest next. Shows which commercial investments are paying back and which are not.
• Ranked roadmap. Sorts the work by how much each item would move the score, so the team spends its time on the few things that matter.
• A read across the whole leadership team. It pulls input from sales, marketing, commercial operations, support, implementation, and finance, and shows where they agree and where they do not.

Three returns on a short investment

• Visibility comes before action. The assessment highlights where the engine is solid, where it is improvised, and where the leadership team does not actually agree.
• Over confidence costs money. A two percent variance against the plan is real money at any revenue scale, and where instruments pull consumables and service behind them, one lost account takes years of that revenue with it rather than one quarter.
• Validation is its own result. If the assessment turns up nothing new, that confirms the current course, and it is cheap next to a miss nobody saw coming.

What is in the sample report

The full report for Larchmere Biosystems, a fictional life science tools company built for this purpose. It runs to 16 pages and covers the six leaders who took part, the score and its band, the nine areas scored and ranked, where the team agrees and where it splits, a 90-day plan with named owners, and the CommEx tools and KPIs behind that plan.

1. Where a leadership team disagrees, and why. Six leaders rated the same 42 statements. Scored through the CCO's answers, the company comes out at 62. Scored through Commercial Operations, it comes out at 24.9. The report shows where that gap sits and how the team closes it.
2. How the priorities get ranked. The nine areas are ranked by how much each would move the score, not by which scores lowest. That ranking becomes a 90-day plan with owners, dates, and the tools and KPIs behind it.
3. Exactly what a client receives. The structure, scoring and output are the same as a live assessment, on a fictional company. You can judge the method before spending any time on it.

Larchmere sits at $45M in revenue with eight sellers. The same assessment runs in companies from around $5M to $250M, with the weighting set to the business.

Larchmere scores 36.2 out of 100, which puts it in the Emerging band. The more useful number is the spread underneath it: rate the company through the Chief Commercial Officer's answers alone and it reads 62.0, and through the Commercial Operations Manager's it reads 24.9. Same company, same quarter.

Client assessments are confidential, so Larchmere is a composite, put together from patterns that come up again and again in companies at this stage. The numbers are illustrative. The structure and the output are exactly what a client receives.

Larchmere's weighted score is 36.2, in the Emerging band. No pillar reaches Scaling. Demand Generation and Pipeline Health, at 18.8, is the only pillar in the Early band, and Predictable Revenue and Forecast Integrity, which carries the most weight at 20%, scores 29.9. Customer Experience and Retention is the strongest pillar at 46.9, still short of Scaling.

The six leaders see the same company very differently. The CCO's answers put Larchmere at 62.0, while Commercial Operations puts it at 24.9 and the CFO at 27.5. The widest split is on forecasting: the CCO scores Forecast Integrity at 70.8 and the CFO at 12.5. The one point of agreement is Demand Generation, which every leader scores low.

The report ranks pillars by how much each would move the score, not by which scores lowest. Predictable Revenue offers the largest lift at 9.0 points because it combines the heaviest weight with a large gap. Demand Generation has the biggest gap but a 10% weight, so it ranks second. Together with Market Strategy, these three account for 20.1 of the 38.8 points available, and they become the first 90 days of the plan.